| 1 | [SID24784417] | Active | EC50 | 0.291 | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast [AID2631, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | EC50 | 0.291 [uM] | | BioAssay | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast | | AID | 2631 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID24784417] | Active | Potency | 0.4611 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 0.4611 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 3 | [SID24784417] | Active | Potency | 0.5805 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 0.5805 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID24784417] | Active | Potency | 0.5805 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 0.5805 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID24784417] | Active | Potency | 0.5805 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 0.5805 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID24784417] | Active | Potency | 0.6513 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID24784417] | Active | Potency | 0.6513 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID24784417] | Active | Potency | 0.6513 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID103711321] | Active | EC50 | 0.99 | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay [AID449704, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103711321 | | CID | 16188433 | | Outcome | Active | | EC50 | 0.99 [uM] | | BioAssay | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | | AID | 449704 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID103711321] | Active | EC50 | 1.207 | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay [AID449703, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103711321 | | CID | 16188433 | | Outcome | Active | | EC50 | 1.207 [uM] | | BioAssay | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | | AID | 449703 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID24784417] | Active | IC50 | 1.39 | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay [AID489035, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | IC50 | 1.39 [uM] | | BioAssay | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay | | AID | 489035 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID24784417] | Active | Potency | 2.0749 | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation in HepG2 cytotox [AID588382, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 2.0749 [uM] | | BioAssay | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation in HepG2 cytotox | | AID | 588382 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID24784417] | Active | Potency | 2.8184 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 14 | [SID24784417] | Active | AC50 | 2.833 | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity [AID540268, Type: confirmatory] | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | AC50 | 2.833 [uM] | | BioAssay | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540268 | | BioAssay type | confirmatory | | Target | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] | | PubMed | | | Data Table |  |
|
| 15 | [SID24784417] | Active | Potency | 3.5481 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 16 | [SID24784417] | Active | Potency | 3.5481 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 17 | [SID24784417] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 18 | [SID24784417] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 19 | [SID24784417] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 20 | [SID24784417] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 21 | [SID24784417] | Active | Potency | 3.5481 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504848, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504848 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID24784417] | Active | AC50 | 3.661 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | AC50 | 3.661 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID24784417] | Active | Potency | 3.6626 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID24784417] | Active | Potency | 3.9811 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504850, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504850 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID24784417] | Active | AC50 | 4.227 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | AC50 | 4.227 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 26 | [SID24784417] | Active | AC50 | 4.227 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | AC50 | 4.227 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 27 | [SID24784417] | Active | AC50 | 4.227 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | AC50 | 4.227 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 28 | [SID24784417] | Active | AC50 | 4.615 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | AC50 | 4.615 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID24784417] | Active | IC50 | 4.92 | Confirmatory Screen: Chemical Inhibitors of TNF alpha stimulated E Selectin expression [AID1288, Type: confirmatory] | selectin E (endothelial adhesion molecule 1) [Homo sapiens] [gi:56417702] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | IC50 | 4.92 [uM] | | BioAssay | Confirmatory Screen: Chemical Inhibitors of TNF alpha stimulated E Selectin expression | | AID | 1288 | | BioAssay type | confirmatory | | Target | selectin E (endothelial adhesion molecule 1) [Homo sapiens] [gi:56417702] | | PubMed | | | Data Table |  |
|
| 30 | [SID24784417] | Active | Potency | 5.1735 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 31 | [SID24784417] | Active | Potency | 5.1735 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 32 | [SID24784417] | Active | Potency | 5.1735 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 33 | [SID24784417] | Active | Potency | 5.1735 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 34 | [SID24784417] | Active | Potency | 5.6234 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID24784417] | Active | Potency | 5.6234 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 36 | [SID24784417] | Active | Potency | 5.6234 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 37 | [SID24784417] | Active | IC50 | 5.7 | Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay [AID489041, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | IC50 | 5.7 [uM] | | BioAssay | Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay | | AID | 489041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID24784417] | Active | Potency | 6.7016 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 6.7016 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 39 | [SID24784417] | Active | Potency | 6.7016 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 6.7016 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 40 | [SID24784417] | Active | Potency | 6.7016 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 6.7016 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 41 | [SID24784417] | Active | Potency | 6.7016 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 6.7016 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 42 | [SID24784417] | Active | Potency | 7.0795 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 43 | [SID24784417] | Active | IC50 | 8.39 | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay [AID489033, Type: confirmatory] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | IC50 | 8.39 [uM] | | BioAssay | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay | | AID | 489033 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID24784417] | Active | Potency | 8.9125 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 45 | [SID24784417] | Active | Potency | 8.9125 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 46 | [SID24784417] | Active | Potency | 11.5539 | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation. [AID588397, Type: confirmatory] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 11.5539 [uM] | | BioAssay | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation. | | AID | 588397 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID24784417] | Active | EC50 | 12.9 | Dose response confirmation of uHTS hits that enhance the survival of human induced pluripotent stem cells when cultured as single cells in a luminescent assay [AID623861, Type: confirmatory] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | EC50 | 12.9 [uM] | | BioAssay | Dose response confirmation of uHTS hits that enhance the survival of human induced pluripotent stem cells when cultured as single cells in a luminescent assay | | AID | 623861 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID24784417] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 49 | [SID24784417] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 50 | [SID24784417] | Active | Potency | 20.5878 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24784417 | | CID | 16188433 | | Outcome | Active | | Potency | 20.5878 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|